1
|
Xia B, Di Chen, Zhang J, Hu S, Jin H and
Tong P: Osteoarthritis pathogenesis: A review of molecular
mechanisms. Calcif Tissue Int. 95:495–505. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Felson DT, Lawrence RC, Dieppe PA, Hirsch
R, Helmick CG, Jordan JM, Kington RS, Lane NE, Nevitt MC, Zhang Y,
et al: Osteoarthritis: New insights. Part 1: The disease and its
risk factors. Ann Intern Med. 133:635–646. 2000. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ashford S and Williard J: Osteoarthritis:
A review. Nurse Pract. 39:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Gokce A, Peak TC, Abdel-Mageed AB and
Hellstrom WJ: Adipose Tissue-derived stem cells for the treatment
of erectile dysfunction. Curr Urol Rep. 17:142016. View Article : Google Scholar : PubMed/NCBI
|
5
|
Sabol RA, Bowles AC, Cote A, Wise R,
Pashos N and Bunnell BA: Therapeutic potential of adipose stem
cells. Adv Exp Med Biol. Jul 27–2018.doi: 10.1007/5584_2018_248
(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
6
|
Pak J, Lee JH, Pak N, Pak Y, Park KS, Jeon
JH, Jeong BC and Lee SH: Cartilage regeneration in humans with
adipose tissue-derived stem cells and adipose stromal vascular
fraction cells: Updated status. Int J Mol Sci. 19(pii): E21462018.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Simpson RJ, Lim JW, Moritz RL and
Mathivanan S: Exosomes: Proteomic insights and diagnostic
potential. Expert Rev Proteomics. 6:267–283. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Tran TH, Mattheolabakis G, Aldawsari H and
Amiji M: Exosomes as nanocarriers for immunotherapy of cancer and
inflammatory diseases. Clin Immunol. 160:46–58. 2015. View Article : Google Scholar : PubMed/NCBI
|
9
|
Barile L and Vassalli G: Exosomes: Therapy
delivery tools and biomarkers of diseases. Pharmacol Ther.
174:63–78. 2017. View Article : Google Scholar : PubMed/NCBI
|
10
|
Li Z, Wang Y, Xiao K, Xiang S, Li Z and
Weng X: Emerging role of exosomes in the joint diseases. Cell
Physiol Biochem. 47:2008–2017. 2018. View Article : Google Scholar : PubMed/NCBI
|
11
|
Arai Y, Park S, Choi B, Ko KW, Choi WC,
Lee JM, Han DW, Park HK, Han I, Lee JH and Lee SH: Enhancement of
Matrix Metalloproteinase-2 (MMP-2) as a potential chondrogenic
marker during chondrogenic differentiation of human adipose-derived
stem cells. Int J Mol Sci. 17(pii): E9632016. View Article : Google Scholar : PubMed/NCBI
|
12
|
Zimmermann T, Kunisch E, Pfeiffer R, Hirth
A, Stahl HD, Sack U, Laube A, Liesaus E, Roth A, Palombo-Kinne E,
et al: Isolation and characterization of rheumatoid arthritis
synovial fibroblasts from primary culture-primary culture cells
markedly differ from fourth-passage cells. Arthritis Res. 3:72–76.
2001. View Article : Google Scholar : PubMed/NCBI
|
13
|
Dai M, Sui B, Xue Y, Liu X and Sun J:
Cartilage repair in degenerative osteoarthritis mediated by squid
type II collagen via immunomodulating activation of M2 macrophages,
inhibiting apoptosis and hypertrophy of chondrocytes. Biomaterials.
180:91–103. 2018. View Article : Google Scholar : PubMed/NCBI
|
14
|
Goldring MB: The role of cytokines as
inflammatory mediators in osteoarthritis: Lessons from animal
models. Connect Tissue Res. 40:1–11. 1999. View Article : Google Scholar : PubMed/NCBI
|
15
|
Naito M, Ohashi A and Takahashi T:
Dexamethasone inhibits chondrocyte differentiation by suppression
of Wnt/β-catenin signaling in the chondrogenic cell line ATDC5.
Histochem Cell Biol. 144:261–272. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Yuan X, Liu H, Huang H, Liu H, Li L, Yang
J, Shi W, Liu W and Wu L: The key role of canonical Wnt/β-catenin
signaling in cartilage chondrocytes. Curr Drug Targets. 17:475–484.
2016. View Article : Google Scholar : PubMed/NCBI
|
17
|
Goldring MB: Anticytokine therapy for
osteoarthritis. Expert Opin Biol Ther. 1:817–829. 2001. View Article : Google Scholar : PubMed/NCBI
|
18
|
Sutton S, Clutterbuck A, Harris P, Gent T,
Freeman S, Foster N, Barrett-Jolley R and Mobasheri A: The
contribution of the synovium, synovial derived inflammatory
cytokines and neuropeptides to the pathogenesis of osteoarthritis.
Vet J. 179:10–24. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Miana VV and Gonzalez EAP: Adipose tissue
stem cells in regenerative medicine. Ecancermedicalscience.
12:8222018. View Article : Google Scholar : PubMed/NCBI
|
20
|
Eirin A, Riester SM, Zhu XY, Tang H, Evans
JM, O'Brien D, van Wijnen AJ and Lerman LO: MicroRNA and mRNA cargo
of extracellular vesicles from porcine adipose tissue-derived
mesenchymal stem cells. Gene. 551:55–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
21
|
Baglio SR, Rooijers K, Koppers-Lalic D,
Verweij FJ, Perez Lanzon M, Zini N, Naaijkens B, Perut F, Niessen
HW, Baldini N and Pegtel DM: Human bone marrow- and
adipose-mesenchymal stem cells secrete exosomes enriched in
distinctive miRNA and tRNA species. Stem Cell Res Ther. 6:1272015.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Hu G, Zhao X, Wang C, Geng Y, Zhao J, Xu
J, Zuo B, Zhao C, Wang C and Zhang X: MicroRNA-145 attenuates
TNF-α-driven cartilage matrix degradation in osteoarthritis via
direct suppression of MKK4. Cell Death Dis. 8:e31402017. View Article : Google Scholar : PubMed/NCBI
|
23
|
Zheng X, Zhao FC, Pang Y, Li DY, Yao SC,
Sun SS and Guo KJ: Downregulation of miR-221-3p contributes to
IL-1β-induced cartilage degradation by directly targeting the
SDF1/CXCR4 signaling pathway. J Mol Med (Berl). 95:615–627. 2017.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Zhang Y, Gao Y, Cai L, Li F, Lou Y, Xu N,
Kang Y and Yang H: MicroRNA-221 is involved in the regulation of
osteoporosis through regulates RUNX2 protein expression and
osteoblast differentiation. Am J Transl Res. 9:126–135.
2017.PubMed/NCBI
|